JUST ANNOUNCED: Special FDA Address: Expediting the Critical Path to Drug Development Leonard Sacks, Deputy Director, Critical Path Program, US Food & Drug Administration (FDA)

Know Where You’re Going:
Set a business roadmap to build success into your strategy and increase potential for commercial viable drugs.

Do More
with Less:
Industry & company-wide initiatives for streamlining, cost-cutting, & metrics for enhanced productivity.

Partner for Success:
Understand ‘customer’ across the value chain to maximize key internal & external stakeholder relationships.

Slash Time to Approvals:
Design your trial to overcome process & performance bottlenecks for faster FDA approval.

Look to the Future:
Forecasts what the new environment of pharma will look like to adapt your clinical operations to thrive NOW.